Diagnosis of cow's milk allergy in children: determining the gold standard?

Christophe Dupont1

  • 1Hôpital Necker-Enfants Malades, Université Paris-Descartes, Paris, France.

Insights

Cow's milk protein allergy (CMPA) impacts multiple organs, causing various symptoms from colic to enterocolitis. Diagnosis involves elimination diets and oral food challenges to confirm reactions and guide management.

Area of Science:

  • Allergy and Immunology
  • Pediatric Gastroenterology
  • Clinical Nutrition

Background:

  • Cow's milk protein allergy (CMPA) is a common condition affecting infants and children.
  • It can manifest with diverse symptoms impacting multiple organ systems, from the gastrointestinal tract to the skin.
  • Reactions can be immediate or delayed, complicating diagnosis and management.

Purpose of the Study:

  • To outline the diagnostic process for CMPA, emphasizing the role of elimination diets and oral food challenges.
  • To differentiate between immediate and delayed reactions and various CMPA-related syndromes.
  • To guide management strategies, including formula selection and reintroduction of milk products.

Main Methods:

  • Clinical history taking and physical examination are primary diagnostic tools.
  • Elimination diets followed by oral food challenges are crucial for diagnosis and treatment.
  • The double-blind-placebo-controlled food challenge is the gold standard for research settings.

Main Results:

  • Most CMPA cases in infants present with delayed reactions, necessitating careful diagnostic approaches.
  • Accurate diagnosis involves identifying the specific syndrome, assessing risks, and choosing appropriate replacement formulas.
  • Monitoring tolerance development and guiding reintroduction of milk products are key to long-term management.

Conclusions:

  • Diagnosing CMPA requires a comprehensive approach beyond simple milk exclusion, focusing on clinical presentation and response to challenges.
  • Management strategies should be individualized based on the child's specific condition and tolerance.
  • Primary care can manage non-IgE mediated CMPA, while complex cases may require referral to specialized centers.